glp 1 and blindness drugs Zepbound Blindness Lawsuit [2026 Update] iLIV Clinic | ๐ You've
Description
Thats how GLP-1 agonists work to control blood sugar in diabetic patients
Subtle conformational dynamics allow the C-terminus of GLP-1 to access the ECD binding site, and the ligand binding triggers further dissociation of the ECD from the TMD allowing the N-terminus of GLP-1 to enter the orthosteric pocket in the TMD and activate the receptor
doi: 10.1210/en.2016-1234 64 TanMChengYZhongXYangDJiangSYeYet al
Print this
It will be regulated by the FDA and used as a legitimate treatment
![glp 1 and blindness drugs Zepbound Blindness Lawsuit [2026 Update] iLIV Clinic | You've](https://i.ytimg.com/vi/W9JWFhRKae0/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLAvKFbfeWwH3GI7mpUt0FYFyCtRtg)